XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance $ 777 $ 841  
Changes in estimated fair value (114) 50  
Payments (119) 0  
Other (2) (12)  
Fair value, ending balance 542 879  
Contingent consideration 542 $ 879  
Current liability 131    
Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, ending balance 402    
Contingent consideration $ 402    
Contingent consideration, measurement input, discount rate 0.115    
Measurement Input, Discount Rate | Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Contingent consideration, measurement input, discount rate 0.06   0.08